Phenotypical and functional characterisation of HIV-specific T cell responses in HIV negative and HIV infected volunteers immunised with GTU MultiHIV B DNA vaccine
Over the last 30 years, HIV-1 has transformed from an untreatable fatal infection to a chronic condition susceptible to over thirty antiretroviral agents. Although the overall incidence of HIV has declined during the last decade, HIV prevention and treatment still remain key public health priorities...
Main Author: | Haidari, Goli |
---|---|
Other Authors: | Shattock, Robin ; Fidler, Sarah |
Published: |
Imperial College London
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.745256 |
Similar Items
-
The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
by: G. Haidari, et al.
Published: (2019-12-01) -
P19-30. GTU<sup>® </sup>as beneficial HIV DNA vaccine vector system
by: Adojaan M, et al.
Published: (2009-10-01) -
P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides
by: Le-Grand R, et al.
Published: (2009-10-01) -
The impact of HIV on measles and measles immunisation
by: Scott, Susana
Published: (2006) -
Characterisation of HIV-specific immunity in a cohort of high-risk Kenyan sex workers
by: Kaul, Rupert
Published: (2001)